Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Champions Oncology (CSBR) Asset Utilization Ratio (2016 - 2026)

Champions Oncology has reported Asset Utilization Ratio over the past 16 years, most recently at 1.98 for Q1 2026.

  • Quarterly results put Asset Utilization Ratio at 1.98 for Q1 2026, down 5.73% from a year ago — trailing twelve months through Jan 2026 was 1.98 (down 5.73% YoY), and the annual figure for FY2025 was 1.95, up 17.36%.
  • Asset Utilization Ratio for Q1 2026 was 1.98 at Champions Oncology, up from 1.92 in the prior quarter.
  • Over the last five years, Asset Utilization Ratio for CSBR hit a ceiling of 2.14 in Q4 2024 and a floor of 1.42 in Q2 2022.
  • Median Asset Utilization Ratio over the past 5 years was 1.79 (2024), compared with a mean of 1.75.
  • Biggest five-year swings in Asset Utilization Ratio: increased 24.34% in 2024 and later fell 10.59% in 2025.
  • Champions Oncology's Asset Utilization Ratio stood at 1.53 in 2022, then increased by 12.32% to 1.72 in 2023, then grew by 24.34% to 2.14 in 2024, then fell by 9.87% to 1.92 in 2025, then grew by 2.73% to 1.98 in 2026.
  • The last three reported values for Asset Utilization Ratio were 1.98 (Q1 2026), 1.92 (Q4 2025), and 1.81 (Q3 2025) per Business Quant data.